✉news WorldUS Politics first seen 1 d ago, last 1 d ago, peak #31
Psychiatrists Discuss REAL-BD Study Results for Long-Acting Aripiprazole in Bipolar I
Original: Post-Psych Congress Recap Part 2: Drs Chepke and Goldberg Discuss REAL-BD Study Exploratory Results for Aripiprazole Monohydrate Every-Two-Month Formulation in Adults Living With Bipolar I Disorder
Drs Chepke and Goldberg, speaking in a recap from a recent psychiatric congress, discussed exploratory results from the REAL-BD study of an every-two-month aripiprazole monohydrate formulation in adults living with bipolar I disorder. The discussion covers what the long-acting injectable data could mean for maintenance treatment of bipolar I, a condition where long-acting options are limited and adherence remains a major clinical challenge.
Why now: New exploratory data on a long-acting injectable treatment for bipolar I disorder are of interest to psychiatrists following the latest congress findings.
ChepkeGoldbergREAL-BD studyaripiprazole monohydratebipolar I disorder
Evidence
- Post-Psych Congress Recap Part 2: Drs Chepke and Goldberg Discuss REAL-BD Study Exploratory Results for Aripiprazole Monohydrate Every-Two-Month Formulation in Adults Living With Bipolar I Disorder · HMP Global Learning Network
API: https://socialmediatrends-api.osmike.com/v1/trends/776017